XYD129

N/A

Report date: 2024/06/04 13:38:00
NME

Base Information

Drug NameXYD129
Drug Alias NameXYD129XYD-129
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp300-CBP transcription factors inhibitors
Targetsp300-CBP transcription factors
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical UniversityUniversity of Chinese Academy of SciencesJilin University
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Chinese Academy of SciencesJilin UniversityShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A